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and subtropical areas. The ﬁrst documented appearance of
DEN-V infection in Kingdom of Saudi Arabia was in Jeddah,
western region in 1994, and the infection is still endemic
in the area. The aim of this study was to determine the
presence and typing of DEN-Vs in hospitalized patients in
western region of Saudi Arabia.
Materials and Methods: Three hundred and ﬁve serum
samples from suspected inpatients were collected during
April to August 2007 and were screened for dengue viruses.
The samples were cultured on C6/36 mosquito cell line
to determine the cytopathic effects and to identify the 4-
serotypes of DEN-Vs using indirect immunoﬂuorescent assay
(IFA). IgM/IgG ELISA assays were also used to detect the inci-
dence of infection. In addition, RT-nested-PCR was used to
detect and identify the types of dengue viruses.
Results: ELISA screening showed that 32(10.5%) samples
were positive for DEN-V IgM, 74(24.2%) were positive for
DEN-V IgG and 56(18.4%) were positive for both IgM and IgG.
IFA revealed 40(13.1%) positive cases of DEN-V, of them:
8(20%) DEN-V1, 7(17.5%) DEN-V2, and 25(62.5%) samples
DEN-V3. The RT-PCR showed that 89(29.2%) samples were
positive for DEN-V, of them 16(17.9%) samples were positive
for DEN-V1, 20(22.5%) DEN-V2 and 53(59.6%) DEN-V3. DEN-
V4 was not detected by RT-PCR and IFA. The seroprevalence
was 162(53.1%), while the incidence was 39(24.1%).
Conclusion: This study showed a high seroprevalence and
low incidence of dengue virus infection in the study popula-
tion. Approximately half of the patients were at a high risk
of developing dengue hemorrhagic fever and dengue shock
syndrome at subsequent infection. Because of its high sen-
sitivity and speciﬁcity, we recommend the use of RT-PCR
for rapid direct diagnosis and typing of dengue viruses in
addition to the conventional methods.
doi:10.1016/j.ijid.2008.05.879
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Background: Réunion Island Chikungunya outbreak begun
on April 2005 and was maximal during the ﬁrst 2006 quar-
ter. For the ﬁrst time a mother to child transmission was
described, viral genome was found in the amniotic liquid,
plasma and cerebrospinal ﬂuid of some fetus and new-born.
We do not know if Chikungunya infection during pregnancy
may cause fetal loss, premature delivery, small for age new-
born or neonatal mortality. Our aim was to study the effect
of Chikungunya outbreak on pregnancy length, new-born
weight, fetal loss and perinatal mortality.
Methods: Data for the 2004—2006 period come from
social and health administrations of Réunion Island witch
collect information about almost each pregnancy and deliv-
ery. During the study period la Caisse d’Allocation Familiale
(Family Allowance Ofﬁce) had registered 41,665 deliveries
with information on fetal loss, still birth and neonatal mor-
tality and la Protection Maternelle et Infantile (Mother and
Child Welfare) 42,359 alive new-born with information on
term, and weight. Deliveries of 2006 ﬁrst quarter were com-
pared to the 2004—2005 ﬁrst quarter.
Results: Abortion and fetal loss before 22 weeks of
pregnancy were not different for the ﬁrst quarter of 2006
compared to 2005 and 2004 (1.1 versus 1.2%). Perinatal mor-
tality (fetal loss after 22 weeks, still-birth and neonatal
mortality before 28 days) was not different for the ﬁrst quar-
ter of 2006 compared to 2005 and 2004 (1.8 versus 1.3%).
Percentage of delivery before 37 weeks was similar for ﬁrst
quarter deliveries of 2006 compared to 2005 and 2004 (9.1
versus 10.1%). Percentage of small-for-age (<10◦p) new-born
was similar for ﬁrst quarter of 2006 compared to 2005 and
2004 (10.5 versus 10.0%).
Conclusion: We do not identify any increased risk of fetal
loss before 22 weeks of pregnancy, perinatal mortality, pre-
mature delivery, small-for-age new-born between January
and March 2006.
doi:10.1016/j.ijid.2008.05.880
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Objectives: The genus Erwinia consists of 12 validated
species which are associated with plants as pathogens, but,
clinical isolates are exceedingly rare; only one species,
Erwinia persicina, has been isolated from the urine of a
woman with a urinary tract infection. Erwinia tasmaniensis
is a recently describe species. It was isolated from ﬂow-
ers and barks of apple and pear trees in Australia, but was
not pathogenic on plants. We presently describe the isola-
tion of a bacterium from the excisional tissue of a patient
with cervical lymphadenitis that was determined to be an
E. tasmaniensis-like organism.
Results: A 79-year-old woman visited a hospital for eval-
uation of left side cervical lymphadenopathy and headache
that had begun three days previously. On physical exam-
ination, her left neck had multiple, 0.5—1.5 cm sized,
tender, conglomerated lymph nodes, but other ﬁndings were
unremarkable. Neck sonography showed multifocal necrotic
lymph node in the left side of the neck with perinodal
inﬁltration. An excisional biopsy was performed. Pathologic
examination revealed central necrosis with peripheral hem-
orrhages, with no evidence of malignancy or tuberculosis.
Culture of tissue obtained from the biopsy isolated a bac-
terium that was identiﬁed as Pantoea sp. by VITEK 2 in the
clinical microbiology laboratory. For more precise identiﬁca-
tion, 16S rRNA gene analysis was undertaken. A 1,289 bp of
the 16S rRNA gene was obtained from the bacterium, which
was designated ABB-Jeju-1. The determined 16S rRNA gene
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sequence was compared via BLAST search at the EzTaxon
public database. As a result of sequence comparison, strains
with the greatest pairwise similarity to strain ABB-Jeju-1
were E. tasmaniensis Et1/99T (98.9%), E. toletana A37T
(98.8%), and E. billingiae LMG 2613T (98.1%). A phyloge-
netic tree based on 16S rRNA gene sequences also suggested
that the strain ABB-Jeju-1 clustered with E. tasmaniensis
ET1/99T, which was supported moderately by the bootstrap
value (66%). Very recently, Stackbrandt and Ebers stated
that a strain with a 16S rRNA gene sequence similarity lower
than 99% with known species should be subjected to testing
as a novel species, by comparison of 16S rRNA gene sequence
similarities and DNA-DNA reassociation values. Accordingly,
strain ABB-Jeju-1 could not be regarded as E. tasmanien-
sis with conﬁdence, and we designated the strain as an E.
tasmaniensis-like organism.
Conclusions: This is the ﬁrst case of human infection due
to Erwinia tasmaniensis-like organism.
doi:10.1016/j.ijid.2008.05.881
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Background: Mortality of 1918 Spanish inﬂuenza in Taiwan
had only been brieﬂy reported around 25,000, causing 0.69%
death rate in previous literature. Here we present a detailed
epidemiology to comprehend its impact in Taiwan.
Methods: Historical records and publications of
‘‘Sotokufu’’ (Japanese colonial government in Taiwan)
era during 1912 to 1925 were reviewed to retrieve relevant
statistics and data. Death rates due to inﬂuenza and
pneumonia (P&I) or combined respiratory tract illnesses
(RTI), including P&I, acute or chronic bronchitis and others,
were calculated using populations of speciﬁc age groups
living in Taiwan based on an island-wide census in 1915
as denominators. Excess deaths were estimated using
the average mortality 5-year before the pandemic as the
baseline.
Results: Two sharp upsurges in P&I mortality by at least
7-fold were detected during October 1918 to January 1919
and December 1919 to March 1920, and resulted in more
than 17,000 and 21,000 excess deaths, respectively, as com-
pared to the same 4-month periods of 1912—1917. During
the pandemic years, annual deaths due to P&I and RTI were
at least 28,000 and 44,000 with mortality rates around 0.83%
and 1.24%, respectively. Annual P&I death rates, compared
to those of 1913—1917, increased disproportionately among
different ages: in 1918, the highest escalation was 5.2-fold
among the 20—30 year-olds and in 1920, 7.7-fold among the
5—10 year-olds; the least was 1.8- to 2.1- fold among the
60’s or older. Similar pattern and trend were detected when
RTI substituted for P&I in the analyses.
Conclusion: In this investigation of epidemiology of Span-
ish inﬂuenza in Taiwan, more than 60,000 P&I deaths in
2 waves separated by 10 months during 1918—1920 were
identiﬁed, with much higher mortality and death rate than
previously recognized. Similar to previous studies, this pan-
demic had resulted in an unusual high mortality to young
people in Taiwan.
doi:10.1016/j.ijid.2008.05.882
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Using vaccines to mitigate the effects of a new inﬂuenza
pandemic will be hindered by limited vaccine production
capacity and delays inherent in the production of inﬂuenza
vaccines. Antigen-sparing vaccines have the most poten-
tial to increase population coverage but this may require a
trade-off in protective efﬁcacy. We used mathematical mod-
elling to investigated this trade-off for vaccines that reduce
susceptibility and/or infectivity, and found that the optimal
dose can be low or high in antigen depending on the vaccine
characteristics and production supply. For published Phase I
trial data this occurs at low antigen levels. We also examined
the effect of timing on the vaccination campaign. With and
R 0 of 2, and early vaccination of 20% of the population,
the ﬁnal serological attack rate could be reduced by 12%
with a two-dose campaign. However, if vaccination was syn-
chronous with the epidemic starting, then one 7.5mcg dose
and two 3.8mcg doses to the same number of people had
similar results with around a 6% reduction in the ﬁnal attack
rate (results based on GSK adjuvanted candidate vaccines).
We also studied the effect of delays in vaccine availability,
distribution rate and time to seroconversion on epidemic
size with dynamic vaccine distribution during an epidemic
of inﬂuenza. We found that a rapid distribution campaign
can control a highly infectious virus if begun while there are
a small number of cases but that the effect is much reduced
by a delay of just 1 month. Our results suggest that anti-
gen sparing vaccines should continue to be pursued and that
if time is critical, a higher, single-dose schedule could be
used. It is important to vaccinate prior to the arrival of the
pandemic when pursuing a two-dose schedule.
doi:10.1016/j.ijid.2008.05.883
